Skip to main content

Table 4 Intra-laboratory reproducibility and inter-laboratory agreement of the CLART4S assay using SurePath screening samples

From: Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening

Assessment and site HPV status Copenhagen Laboratory Result 1 Total Kappa Lower bound
Hr-HPV positive Hr-HPV negative
Intra-laboratory Reproducibility
Copenhagen laboratory result 2 Hr-HPV positive 125 13 138 0.87 0.93
Hr-HPV negative 14 388 402
Total 139 401 540
Inter-laboratory Agreement
Edinburgh Laboratory result Hr-HPV positive 88 6 94 0.69 0.87
Hr-HPV negative 51 395 446
Total 139 401 540